iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Short Interest Update

by · The Cerbat Gem

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA – Get Free Report) was the recipient of a large decrease in short interest in December. As of December 31st, there was short interest totaling 1,277 shares, a decrease of 86.5% from the December 15th total of 9,491 shares. Based on an average daily volume of 17,516 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.0% of the shares of the stock are sold short. Currently, 0.0% of the shares of the stock are sold short. Based on an average daily volume of 17,516 shares, the days-to-cover ratio is presently 0.1 days.

Institutional Investors Weigh In On iShares Genomics Immunology and Healthcare ETF

Large investors have recently modified their holdings of the stock. Triumph Capital Management purchased a new stake in iShares Genomics Immunology and Healthcare ETF in the third quarter worth about $35,000. Flow Traders U.S. LLC purchased a new position in shares of iShares Genomics Immunology and Healthcare ETF in the 2nd quarter valued at approximately $931,000. Ameriprise Financial Inc. lifted its stake in shares of iShares Genomics Immunology and Healthcare ETF by 8.4% in the 3rd quarter. Ameriprise Financial Inc. now owns 71,473 shares of the company’s stock valued at $1,688,000 after purchasing an additional 5,540 shares during the period. Finally, Portland Global Advisors LLC bought a new stake in shares of iShares Genomics Immunology and Healthcare ETF during the second quarter valued at approximately $2,099,000.

iShares Genomics Immunology and Healthcare ETF Stock Down 0.6%

Shares of IDNA traded down $0.18 during mid-day trading on Monday, hitting $27.64. 32,626 shares of the company’s stock traded hands, compared to its average volume of 49,332. The firm has a market capitalization of $138.20 million, a P/E ratio of 14.76 and a beta of 1.07. The business’s 50-day moving average price is $26.45 and its 200-day moving average price is $24.06. iShares Genomics Immunology and Healthcare ETF has a 1 year low of $17.26 and a 1 year high of $28.10.

About iShares Genomics Immunology and Healthcare ETF

(Get Free Report)

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.

Featured Stories